HIGHLINE MEDICAL CENTER
1. Target Overview & Investment Thesis
HIGHLINE MEDICAL CENTER is a 132-bed under-performing / distressed in KING, WA with $168.8M in net patient revenue and a -28.6% operating margin. The hospital serves a payer mix of 22.0% Medicare, 8.7% Medicaid, and 69.4% commercial.
Thesis: Undervalued. Our ML models identify $12.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -28.6% to -21.3% (+736bps).
| Net Revenue HCRIS | $168.8M |
| Current EBITDA COMPUTED | $-48.3M |
| Operating Margin COMPUTED | -28.6% |
| Occupancy HCRIS | 61.0% |
| Revenue / Bed COMPUTED | $1.3M |
| Net-to-Gross HCRIS | 15.8% |
| Distress Probability ML | 44.9% |
2. Market Context & Competitive Position
WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -28.6% places it below the state median. Among 32 size-comparable peers (66-264 beds), the median margin is -9.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (66-264), prioritizing same-state peers. 32 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HIGHLINE MEDICAL CENTER (Target) | WA | 132 | $168.8M | -28.6% |
| VIRGINIA MASON MEDICAL CENTER | WA | 222 | $1.11B | -23.2% |
| ST. JOSEPH MEDICAL CENTER | WA | 208 | $750.0M | 1.9% |
| HARRISON MEDICAL CENTER | WA | 238 | $653.4M | 2.2% |
| CENTRAL WASHINGTON HOSPITAL | WA | 176 | $550.9M | -2.0% |
| YAKIMA VALLEY MEMORIAL HOSPITA | WA | 208 | $522.3M | -10.4% |
| LEGACY SALMON CREEK HOSPITAL | WA | 178 | $479.7M | -5.2% |
| SWEDISH MEDICAL CENTER CHERRY | WA | 181 | $463.4M | -15.0% |
| PHD#1 DBA SKAGIT VALLEY HOSPI | WA | 137 | $414.3M | -17.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $108K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-48.3M |
| + RCM Uplift | +$12.4M |
| Pro Forma EBITDA | $-35.9M |
| Current Margin | -28.6% |
| Pro Forma Margin | -21.3% |
| WC Released (1x) | $6.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-74.3M | $-194.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-74.3M | $-238.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-66.9M | $-221.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-66.9M | $-261.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-81.8M | $-232.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-81.8M | $-282.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 32 hospitals with 66-264 beds
- Same-state prioritization (n=33)
- Comp margins: P25=-18.7% / P50=-9.7% / P75=-1.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.